Varenicline Oxalate

草酸伐尼克兰

Report date: 2024/01/02 20:03:52
NME

Base Information

Drug NameVarenicline Oxalate
Drug Alias NameHIP-1502
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNicotinic acetylcholine receptor alpha-4/beta-2 agonists
TargetsNicotinic acetylcholine receptor alpha-4/beta-2
Therapy Area/IndicationsCigarette SmokingTobacco SmokingMarijuana Use +[8] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSouth AfricaSouth Korea
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesKorea University
China Registration ClassN/A

Develop Information

Active CompaniesJohns Hopkins UniversityMedical University Of South Carolina
Inactive CompaniesKorea University Anam Hospital
Active IndicationsCigarette SmokingTobacco SmokingMarijuana Use +[8] 
Inactive IndicationsN/A

Other Information

ATC CodeN07BA03
Related LinksWikipediaDrugBankKEGG